Cargando…
Buprenorphine Telehealth Treatment Initiation and Follow-Up During COVID-19
Autores principales: | Samuels, Elizabeth A., Khatri, Utsha G., Snyder, Hannah, Wightman, Rachel S., Tofighi, Babak, Krawczyk, Noa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722662/ https://www.ncbi.nlm.nih.gov/pubmed/34981357 http://dx.doi.org/10.1007/s11606-021-07249-8 |
Ejemplares similares
-
Using telehealth to improve buprenorphine access during and after COVID-19: A rapid response initiative in Rhode Island
por: Clark, Seth A., et al.
Publicado: (2021) -
A Telemedicine Buprenorphine Clinic to Serve New York City: Initial Evaluation of the NYC Public Hospital System's Initiative to Expand Treatment Access During the COVID-19 Pandemic
por: Tofighi, Babak, et al.
Publicado: (2022) -
A Brief Educational Intervention to Increase ED Initiation of Buprenorphine for Opioid Use Disorder (OUD)
por: Khatri, Utsha G., et al.
Publicado: (2022) -
Buprenorphine Dispensing in Pennsylvania During the COVID-19 Pandemic, January to October 2020
por: Chalasani, Rohan, et al.
Publicado: (2021) -
Pandemic telehealth flexibilities for buprenorphine treatment: A synthesis of evidence and policy implications for expanding opioid use disorder care in the U.S.
por: Krawczyk, Noa, et al.
Publicado: (2023)